First Time Loading...

Genmab A/S
NASDAQ:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
NASDAQ:GMAB
Watchlist
Price: 28.75 USD 3.83% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one GMAB stock under the Base Case scenario is 45.81 USD. Compared to the current market price of 28.75 USD, Genmab A/S is Undervalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GMAB Relative Value
Base Case
45.81 USD
Undervaluation 37%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.8
P/S
P/S
Price to Sales
7.8
vs History
96
vs Industry
54
Median 3Y
13.7
Median 5Y
15.8
Industry
8.1
Forward
6.4
More Details
29.5
P/E
P/E
Price to Earnings
29.5
vs History
80
vs Industry
6
Median 3Y
35.5
Median 5Y
38
Industry
26.2
Forward
23.7
More Details
17.4
P/OCF
P/OCF
Price to OCF
17.4
vs History
96
vs Industry
10
Median 3Y
31.8
Median 5Y
46.6
Industry
22.6
More Details
18.6
P/FCFE
P/FCFE
Price to FCFE
18.6
vs History
96
vs Industry
7
Median 3Y
33.4
Median 5Y
50
Industry
21.3
More Details
4.1
P/B
P/B
Price to Book Value
4.1
vs History
96
vs Industry
24
Median 3Y
6.7
Median 5Y
7.2
Industry
2.5
More Details
6.1
EV/S
EV/S
Enterprise Value to Sales
6.1
vs History
96
vs Industry
50
Median 3Y
12.1
Median 5Y
13.8
Industry
7.3
Forward
5
More Details
6.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.2
vs History
19
vs Industry
53
Median 3Y
0
Median 5Y
0
Industry
9.1
More Details
17.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
17.9
vs History
90
vs Industry
7
Median 3Y
25.2
Median 5Y
30.7
Industry
4.4
Forward
15.2
More Details
18.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
18.9
vs History
83
vs Industry
7
Median 3Y
25.2
Median 5Y
32.4
Industry
4.3
Forward
16.2
More Details
13.6
EV/OCF
EV/OCF
Enterprise Value to OCF
13.6
vs History
96
vs Industry
10
Median 3Y
28.8
Median 5Y
42.1
Industry
5.4
More Details
14.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
14.3
vs History
96
vs Industry
8
Median 3Y
29.9
Median 5Y
44.4
Industry
3.2
More Details
14
EV/IC
EV/IC
Enterprise Value to IC
14
vs History
95
vs Industry
17
Median 3Y
24.7
Median 5Y
27.1
Industry
5
More Details

Multiples Across Competitors

GMAB Competitors Multiples
Genmab A/S Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Genmab A/S
NASDAQ:GMAB
127.9B USD 7.8 29.5 17.9 18.9
US
Abbvie Inc
NYSE:ABBV
288.7B USD 5.3 59.9 13 19.8
US
Amgen Inc
NASDAQ:AMGN
147.9B USD 5.2 22 16.4 24.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103B USD 10.4 28.5 22.8 23.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
98.5B USD 7.5 24.9 16.5 18.2
AU
CSL Ltd
ASX:CSL
132.6B AUD 6.1 35 21.2 26.3
US
Gilead Sciences Inc
NASDAQ:GILD
81.6B USD 3 14.4 7.9 10.2
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Moderna Inc
NASDAQ:MRNA
41.7B USD 6.1 -8.8 -9.3 -7.9
US
Biogen Inc
NASDAQ:BIIB
31.3B USD 3.2 27 14.6 18.1
KR
Celltrion Inc
KRX:068270
39.2T KRW 18 73.1 44.7 61.6

See Also

Summary
GMAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
GMAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GMAB stock valuation using valuation multiples.
Wall Street Estimates
GMAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GMAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.